company background image
CLVR

Clever Leaves Holdings NasdaqCM:CLVR Stock Report

Last Price

US$0.60

Market Cap

US$25.9m

7D

0%

1Y

-92.0%

Updated

02 Oct, 2022

Data

Company Financials +
CLVR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends0/6

CLVR Stock Overview

Clever Leaves Holdings Inc. operates as a cannabis company.

Clever Leaves Holdings Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Clever Leaves Holdings
Historical stock prices
Current Share PriceUS$0.60
52 Week HighUS$7.65
52 Week LowUS$0.58
Beta1.08
1 Month Change-24.92%
3 Month Change-37.94%
1 Year Change-91.97%
3 Year Change-94.00%
5 Year Changen/a
Change since IPO-93.76%

Recent News & Updates

Sep 21

Clever Leaves partners with House of Kush for international expansion

Clever Leaves (NASDAQ:CLVR) partners with U.S. cannabis-branded genetic innovation company, House of Kush, to be the exclusive grower and distributor of proprietary genetics globally. The company will be the exclusive producer of various genetics for House of Kush outside of the United States and Canada. It will cultivate and commercialize House of Kush proprietary genetics in its Colombia and Portugal facilities for the duration of the three-year agreement, after completing an initial evaluation and adaptation phase of the genetics for each production location. This partnership will further strengthen the company's portfolio of high THC smokable flower which is already being sold in Germany, Israel, and Australia. Andres Fajardo, Clever Leaves’ CEO, stated, “The strategic partnership with House of Kush leverages both companies core capabilities. On the one hand, it will allow Clever Leaves to further expand its flower portfolio with globally renowned genetics. On the other hand, it will serve as a platform for House of Kush to expand their coverage beyond the United States and Canada. Together we will be able to bring high quality product to patients at a global level on a consistent basis.”

Aug 11

Clever Leaves reports Q2 results

Clever Leaves press release (NASDAQ:CLVR): Q2 Revenue of $4.7M (+28.1% Y/Y) misses by $0.85M. Based on sustained commercial momentum across its target markets, the Company continues to expect its full year 2022 revenue to be within the range of $20 million and $25 million, with adjusted gross margin expected to range between 50% and 55%. Clever Leaves also expects adjusted EBITDA to range between $(23) million and $(20) million. In addition, the Company expects approximately $2 million to $3 million of annual capital expenditures.

Shareholder Returns

CLVRUS PharmaceuticalsUS Market
7D0%-0.04%-2.5%
1Y-92.0%3.2%-23.2%

Return vs Industry: CLVR underperformed the US Pharmaceuticals industry which returned 3.2% over the past year.

Return vs Market: CLVR underperformed the US Market which returned -23.2% over the past year.

Price Volatility

Is CLVR's price volatile compared to industry and market?
CLVR volatility
CLVR Average Weekly Movement14.5%
Pharmaceuticals Industry Average Movement11.3%
Market Average Movement6.8%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: CLVR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.

Volatility Over Time: CLVR's weekly volatility has decreased from 26% to 14% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2017560Andres Fajardohttps://www.cleverleaves.com

Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally.

Clever Leaves Holdings Inc. Fundamentals Summary

How do Clever Leaves Holdings's earnings and revenue compare to its market cap?
CLVR fundamental statistics
Market CapUS$25.89m
Earnings (TTM)-US$40.19m
Revenue (TTM)US$18.11m

1.4x

P/S Ratio

-0.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CLVR income statement (TTM)
RevenueUS$18.11m
Cost of RevenueUS$11.86m
Gross ProfitUS$6.24m
Other ExpensesUS$46.43m
Earnings-US$40.19m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.93
Gross Margin34.48%
Net Profit Margin-221.98%
Debt/Equity Ratio2.5%

How did CLVR perform over the long term?

See historical performance and comparison